Original news and analysis on international IP policy
Pharmaceutical manufacturer Eli Lilly today announced a stepped-up commitment to provide improved access to quality healthcare for 30 million people in resource-limited settings by 2030.
The World Health Organization pandemic influenza framework advisory group is meeting this week, behind closed doors. A consultation is expected to take place on 20 October with stakeholders, and an information session has been organised on 21 October on the work of the advisory group, but no press is allowed in either meeting nor able to obtain any information about any aspect of the week’s events.
A side event to last week’s annual General Assemblies of the World Intellectual Property Organization looked at ways for developing countries to design sui generis system for protecting new varieties of plant. The event also looked into the technical assistance provided by WIPO, which, according to the groups, focuses only on the International Union for the Protection of New Varieties of Plants (UPOV) system.
The somewhat puzzling suspense around which countries would be home to new country offices of the World Intellectual Property Organization was partially resolved as the annual WIPO General Assembly came to end yesterday after working till dawn on the bureaucratic issue. Only two candidates out of six could be agreed upon, both in Africa: Algeria and Nigeria. WIPO member states also agreed to amend the organisation’s oversight charter. But they had no luck on the decision to hold a high-level meeting to conclude a treaty on industrial designs.
After much negotiation, amendments to a World Intellectual Property Organization internal oversight mechanism were adopted today by the annual WIPO General Assembly. Under the amendments, investigating allegations of wrongdoing of high-ranking WIPO officials will be made more transparent and facilitate access to documents by WIPO member states in case of an investigation.
As the 2016 World Intellectual Property Organization General Assemblies near their close on 11 October, Intellectual Property Watch provides an update on what’s been agreed and what’s still outstanding among the key issues.
A European civil society group defending rights and freedoms in the digital environment awarded Facebook the Belgian Big Brother Awards 2016 yesterday.
“Great victory”, “life-changing”, “historic milestone” - no adjectives were strong enough yesterday to celebrate the entry into force of the Marrakesh treaty at the World Intellectual Property Organization. The treaty, which went into effect on 30 September, "opens the door to the world's knowledge," to visually impaired people, but will need many more countries to join, in particular countries that are major producers of special format books - the United States and the European Union.
As autumn rolled in, two United Nations agencies chose global figures to help them with their missions, another has a new website, and changed heads, while non-governmental organisations, law offices, and industry also saw numerous changes at management level.
This morning at the World Intellectual Property Organization General Assemblies, WIPO Director General Francis Gurry commented on the success of the WIPO Conference on the Global Digital Content Market, which took place in April. But the full video of the keynote speaker, who had sharp words for corporate internet giants and other new technologies, is missing from the archive.
Has the adoption of the World Intellectual Property Organization Development Agenda in 2007 changed the culture of the organisation, and what did it achieve? According to panellists at a side event to this week’s WIPO General Assembly, the Development Agenda has not yet changed the culture of the organisation and its primary focus to support and protect intellectual property. However, WIPO should follow the United Nations Sustainable Development Goals and collaborate with other UN agencies to include development consideration in its work, they say.
The emphasis placed on the protection and enforcement of intellectual property for medicines in trade negotiations is ignoring the distorting effects of this emphasis, such as the lack of competition incentives which are key to reduce medicines prices, speakers on a panel of generic drug industries said at the World Trade Organization Public Forum last week.